Group One Trading, L.P. Applied Genetic Technologies Corp Transaction History

Group One Trading, L.P.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	SELL	$0.29 - $0.89 $1,053 - $3,232	-3,632 Reduced 47.1%	4,080 $1,000
Q2 2022 Aug 11, 2022	SELL	$0.62 - $1.1 $9,939 - $17,635	-16,032 Reduced 67.52%	7,712 $6,000
Q1 2022 May 12, 2022	BUY	$1.07 - $2.71 $22,710 - $57,519	21,225 Added 842.6%	23,744 $25,000
Q4 2021 Feb 11, 2022	SELL	$1.87 - $2.91 $60,894 - $94,761	-32,564 Reduced 92.82%	2,519 $5,000
Q3 2021 Nov 12, 2021	SELL	$3.01 - $4.12 $13,891 - $19,013	-4,615 Reduced 11.63%	35,083 $106,000
Q2 2021 Aug 10, 2021	SELL	$3.62 - $5.23 $122,026 - $176,298	-33,709 Reduced 45.92%	39,698 $155,000
Q1 2021 May 12, 2021	BUY	$3.94 - $8.19 $176,173 - $366,207	44,714 Added 155.84%	73,407 $372,000
Q4 2020 Feb 10, 2021	SELL	$3.99 - $5.7 $16,430 - $23,472	-4,118 Reduced 12.55%	28,693 $117,000
Q3 2020 Nov 12, 2020	BUY	$4.38 - $6.43 $111,497 - $163,682	25,456 Added 346.1%	32,811 $159,000
Q2 2020 Aug 13, 2020	BUY	$3.0 - $6.9 $22,065 - $50,749	7,355 New	7,355 $41,000

Ticker AGTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,632,200
Description
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.